Articles published by Syros Pharmaceuticals
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
SYRS
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
August 12, 2024
Via Business Wire
Tickers
SYRS
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240724051062/en/2194581/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240613264695/en/2158290/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20240514351941/en/2129503/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240507063235/en/2121500/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240507911048/en/2121492/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240409254657/en/2092648/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20240402068298/en/2086001/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240327550024/en/2081362/22/Syros_Logo.jpg)
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
March 27, 2024
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240325462203/en/2076916/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20240320845080/en/2071744/22/Syros_Logo.jpg)
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
March 20, 2024
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240227887206/en/2043875/22/Syros_Logo.jpg)
Syros to Participate in TD Cowen 44th Annual Health Care Conference
February 27, 2024
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20240108581653/en/1989686/22/Syros_Logo.jpg)
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
January 08, 2024
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20231218719088/en/1974487/22/Syros_Logo.jpg)
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
December 19, 2023
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20231206147296/en/1960937/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20231121742692/en/1950128/22/Syros_Logo.jpg)
Syros to Participate in Upcoming Investor Conferences
November 21, 2023
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20231114402254/en/1941553/22/Syros_Logo.jpg)
Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
November 14, 2023
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20231107787109/en/1936152/22/Syros_Logo.jpg)
Syros to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
November 07, 2023
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20231002277424/en/1903384/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230907173442/en/1883542/22/Syros_Logo.jpg)
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 07, 2023
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230808179533/en/1860941/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230804232313/en/1859794/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230801164906/en/1853786/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230705495927/en/1832780/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230608005068/en/1812725/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230601005849/en/1808639/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
![](https://mms.businesswire.com/media/20230525005247/en/1802969/22/Syros_Logo.jpg)
![](https://mms.businesswire.com/media/20230510005199/en/1788709/22/Syros_Logo.jpg)
Via Business Wire
Tickers
SYRS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.